Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching

<p dir="ltr">Bariatric metabolic surgery (BMS) is a common intervention for severe obesity, yet its effects on cancer risk remain unclear. Observational studies and meta-analyses yield inconsistent findings, while randomized controlled trials often lack adequate follow-up to evaluate...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Jazeel Abdulmajeed (20864819) (author)
مؤلفون آخرون: Zumin Shi (14151978) (author), Manar E. Abdel-Rahman (16122263) (author), Fakhar Shahid (16441932) (author), Mohammed F. Alam (23395475) (author), Mashael Al-Shafai (21620264) (author), Muhammad E. H. Chowdhury (14571275) (author), Abdullah Shaito (20545181) (author), Adedayo A. Onitilo (14833146) (author), Suhail A. R. Doi (20906984) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513522590810112
author Jazeel Abdulmajeed (20864819)
author2 Zumin Shi (14151978)
Manar E. Abdel-Rahman (16122263)
Fakhar Shahid (16441932)
Mohammed F. Alam (23395475)
Mashael Al-Shafai (21620264)
Muhammad E. H. Chowdhury (14571275)
Abdullah Shaito (20545181)
Adedayo A. Onitilo (14833146)
Suhail A. R. Doi (20906984)
author2_role author
author
author
author
author
author
author
author
author
author_facet Jazeel Abdulmajeed (20864819)
Zumin Shi (14151978)
Manar E. Abdel-Rahman (16122263)
Fakhar Shahid (16441932)
Mohammed F. Alam (23395475)
Mashael Al-Shafai (21620264)
Muhammad E. H. Chowdhury (14571275)
Abdullah Shaito (20545181)
Adedayo A. Onitilo (14833146)
Suhail A. R. Doi (20906984)
author_role author
dc.creator.none.fl_str_mv Jazeel Abdulmajeed (20864819)
Zumin Shi (14151978)
Manar E. Abdel-Rahman (16122263)
Fakhar Shahid (16441932)
Mohammed F. Alam (23395475)
Mashael Al-Shafai (21620264)
Muhammad E. H. Chowdhury (14571275)
Abdullah Shaito (20545181)
Adedayo A. Onitilo (14833146)
Suhail A. R. Doi (20906984)
dc.date.none.fl_str_mv 2025-11-11T00:00:00Z
dc.identifier.none.fl_str_mv 10.17305/bb.2025.12842
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Bariatric_metabolic_surgery_and_cancer_risk_Target_trial_emulation_using_iterative_time_distribution_matching/31440106
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Medical biochemistry and metabolomics
Oncology and carcinogenesis
Health sciences
Epidemiology
Public health
Cancer
bariatric metabolic surgery
immortal time bias
iterative time distribution matching
observational study
dc.title.none.fl_str_mv Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Bariatric metabolic surgery (BMS) is a common intervention for severe obesity, yet its effects on cancer risk remain unclear. Observational studies and meta-analyses yield inconsistent findings, while randomized controlled trials often lack adequate follow-up to evaluate cancer outcomes. This study aims to emulate a target trial using observational data, employing a transparent and robust methodology to address this issue. We constructed a large retrospective cohort of adults with obesity in Qatar using electronic medical records from the public health system, with data available from 2018. We developed and applied iterative time distribution matching (ITDM) which is an iterative version of prescription time distribution matching (PTDM) as an improved approach to mitigate immortal time bias. This adaptation facilitated the alignment of time-zero (T0) between BMS recipients and non-recipients. Subsequently, we applied a Cox proportional hazards regression model, controlling for confounders and prognostic covariates, for data analysis. The final study cohort comprised 124,780 individuals aged 30 years and older, including 1,465 who underwent BMS and 1,583 who developed cancer during the follow-up period. The median follow-up duration was 7.79 years (IQR: 4.89-10.85). In the confounder- and prognostic covariate-adjusted Cox model, BMS was associated with a reduced hazard of cancer (HR 0.49, 95% CI 0.31 to 0.76). Given potential residual confounding and the limited outcome data, these findings provide preliminary evidence of a protective association and should be interpreted cautiously. This approach emphasizes transparency in trial emulation design, and future studies should focus on specific cancer types and long-term outcomes as additional data become available.</p><h2 dir="ltr">Other Information</h2><p dir="ltr">Published in: Biomolecules and Biomedicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" rel="noopener noreferrer" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.17305/bb.2025.12842" rel="noreferrer" target="_blank">https://dx.doi.org/10.17305/bb.2025.12842</a></p>
eu_rights_str_mv openAccess
id Manara2_bffe0522f1395996d7bac2b9f630720a
identifier_str_mv 10.17305/bb.2025.12842
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/31440106
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matchingJazeel Abdulmajeed (20864819)Zumin Shi (14151978)Manar E. Abdel-Rahman (16122263)Fakhar Shahid (16441932)Mohammed F. Alam (23395475)Mashael Al-Shafai (21620264)Muhammad E. H. Chowdhury (14571275)Abdullah Shaito (20545181)Adedayo A. Onitilo (14833146)Suhail A. R. Doi (20906984)Biomedical and clinical sciencesMedical biochemistry and metabolomicsOncology and carcinogenesisHealth sciencesEpidemiologyPublic healthCancerbariatric metabolic surgeryimmortal time biasiterative time distribution matchingobservational study<p dir="ltr">Bariatric metabolic surgery (BMS) is a common intervention for severe obesity, yet its effects on cancer risk remain unclear. Observational studies and meta-analyses yield inconsistent findings, while randomized controlled trials often lack adequate follow-up to evaluate cancer outcomes. This study aims to emulate a target trial using observational data, employing a transparent and robust methodology to address this issue. We constructed a large retrospective cohort of adults with obesity in Qatar using electronic medical records from the public health system, with data available from 2018. We developed and applied iterative time distribution matching (ITDM) which is an iterative version of prescription time distribution matching (PTDM) as an improved approach to mitigate immortal time bias. This adaptation facilitated the alignment of time-zero (T0) between BMS recipients and non-recipients. Subsequently, we applied a Cox proportional hazards regression model, controlling for confounders and prognostic covariates, for data analysis. The final study cohort comprised 124,780 individuals aged 30 years and older, including 1,465 who underwent BMS and 1,583 who developed cancer during the follow-up period. The median follow-up duration was 7.79 years (IQR: 4.89-10.85). In the confounder- and prognostic covariate-adjusted Cox model, BMS was associated with a reduced hazard of cancer (HR 0.49, 95% CI 0.31 to 0.76). Given potential residual confounding and the limited outcome data, these findings provide preliminary evidence of a protective association and should be interpreted cautiously. This approach emphasizes transparency in trial emulation design, and future studies should focus on specific cancer types and long-term outcomes as additional data become available.</p><h2 dir="ltr">Other Information</h2><p dir="ltr">Published in: Biomolecules and Biomedicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" rel="noopener noreferrer" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.17305/bb.2025.12842" rel="noreferrer" target="_blank">https://dx.doi.org/10.17305/bb.2025.12842</a></p>2025-11-11T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.17305/bb.2025.12842https://figshare.com/articles/journal_contribution/Bariatric_metabolic_surgery_and_cancer_risk_Target_trial_emulation_using_iterative_time_distribution_matching/31440106CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/314401062025-11-11T00:00:00Z
spellingShingle Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
Jazeel Abdulmajeed (20864819)
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Oncology and carcinogenesis
Health sciences
Epidemiology
Public health
Cancer
bariatric metabolic surgery
immortal time bias
iterative time distribution matching
observational study
status_str publishedVersion
title Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
title_full Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
title_fullStr Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
title_full_unstemmed Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
title_short Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
title_sort Bariatric metabolic surgery and cancer risk: Target trial emulation using iterative time distribution matching
topic Biomedical and clinical sciences
Medical biochemistry and metabolomics
Oncology and carcinogenesis
Health sciences
Epidemiology
Public health
Cancer
bariatric metabolic surgery
immortal time bias
iterative time distribution matching
observational study